MRI proves worthwhile for assessing MS patients in the emergency room

While it’s not a part of established diagnostic criteria, the use of MRI in the emergency department (ED) to evaluate multiple sclerosis (MS) patients for possible exacerbations pays good diagnostic and care-management dividends, according to study conducted at Johns Hopkins and published online Oct. 6 in the American Journal of Neuroradiology.

Senior study author David Yousem, MD, MBA, and colleagues looked into the “worthwhile vs. wasteful” question after noting increasing use of their ED’s MRI scanner and wondering if the pricey exams added demonstrable value to certain patient groups.

For the present study, they specifically hypothesized that the use of emergency MRI to identify active demyelination in MS patients presenting with new neurologic symptoms would yield little useful diagnostic information.

To test this, the team reviewed the medical records of 115 patients with MS who received emergency department MRI scans for a suspected MS exacerbation over the two-year period ending in March of this year.

They found that 41.7 percent (48 of the 115) were ultimately diagnosed with an MS exacerbation.

Of these 48, nearly all (87.5 percent, n = 42) had active demyelination on their emergency department MR imaging. The demyelination was identified on 30.6 percent (33/108) of brain MRIs and 20.4 percent (19/93) of spinal MRIs.

The presence of active demyelination at MRI was thus significantly associated with the ultimate diagnosis of an MS exacerbation (P < .001), the authors report.

In their conclusions, Yousem and colleagues note that the demonstration of MRI’s clear utility for MS patients in these clinical situations “has corresponding downstream impact on management decisions to admit and/or administer intravenous steroids.”

However, they raise the question of whether clinicians “over-rely on emergency department imaging for making exacerbation diagnoses.”

“Additionally, spinal MR imaging is of questionable value as an addition to brain MR imaging due to a low yield of isolated spinal disease.”

Prompting this conclusion was the team’s finding that MR imaging activity isolated to the spinal cord—that which didn’t turn up on concurrent brain MR imaging—was present in only 9 of 93 (9.7 percent) cases.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.